Use our new account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Life & the LawEnd of Life

Assisted Suicide Considered in the Nation’s Capital

Update (10/5/2016): By a close 3-2 vote, the D.C. Health and Human Services Committee voted in favor of moving forward B21-38 for the full Council vote on October 18, 2016.

 

On October 5, the District of Columbia’s Committee on Health and Human Services (HHS) will mark-up and vote on a bill to legalize physician-assisted suicide. The so-called “Death with Dignity Act” (Bill 21-0038) would permit D.C. adult residents to request and be prescribed drugs to end their lives, if they are given a prognosis of six months or less to live. Last year, during a hearing on the legislation, the Director of D.C.’s Department of Health testified in staunch opposition as the executive witness, stating that the bill would “catapult the District into uncharted territories.”

 

During this Wednesday’s committee mark-up, the District’s HHS Committee will consider proposed amendments to the bill, which was originally introduced in January 2015 by Councilwoman Mary Cheh (Ward 3). If the bill is voted out of committee, the full 13-member D.C. Council will vote on the legislation later this year.

 

Bill 21-38 is modeled after Oregon’s assisted suicide law, which has been in effect since 1997. As such, the bill contains many of the same flaws that have failed to protect especially vulnerable populations in Oregon. One major example: it does not require a mental health assessment for each requesting individual, allowing depressed, sick patients to fall through the cracks. Last year in Oregon, only 3.8 percent of the people who died under the law were referred for psychological evaluation. Furthermore, a 2008 study published in the British Medical Journal found that for Oregon, three of 15 participating patients who received a prescription for the lethal dose under the law met the criteria for depression. “All three depressed participants died by legal ingestion within two months of the research interview.” The study authors concluded that “the current practice of the Death with Dignity Act may fail to protect some patients whose choices are influenced by depression from receiving a prescription for a lethal drug.”

 

 

Supporters of assisted suicide often claim that the practice allows people to plan for their own “peaceful exit.” Yet, the Oregon annual reports present a clear challenge to this narrative. For instance, the 2015 report shows that at least one patient died 34 hours after ingestion of the lethal dose, and in a previous year, someone died 104 hours after ingestion. The 2015 report also notes that complications after ingestion of the lethal dose are “unknown” for 80 percent of people dying under the law. This is due to the fact that there is no requirement to have any witness at the time of the patient’s ingestion of the lethal drugs.

 

These concerns and many more were brought before the D.C. Council last July during a public hearing on the bill, which lasted nine hours. Seventy witnesses testified – among them, dozens of disability rights advocates, physicians, and D.C. residents who oppose the assisted suicide legislation.

 

In particular, the D.C. Director of Health, LaQuandra Nesbitt, M.D., expressed her opposition to the bill, emphasizing numerous concerns for D.C.’s residents, and even taking a few moments to correct supporters on terminology – that, from a medical standpoint, the bill does indeed deal with “assisted suicide,” the taking of one’s life.

 

Dr. Nesbitt also stressed a point, especially heightened for the District of Columbia, saying,

 

“[W]e have substantive concerns with the bill, as drafted, particularly with the provision permitting a person to take the lethal medication in a public place… while the drafters of the Oregon bill may have contemplated a natural surrounding in the Northwest Territories of the United States, the District attracts 19 million tourists a year and assisted deaths in highly visible and highly public areas could easily lead to public distress and disorder.”

 

Aside from this specific legislation’s numerous flaws, physician-assisted suicide itself contradicts the role of medicine. The American Medical Association rightfully states in its official opinion, “Physician-assisted suicide is fundamentally incompatible with the physician’s role as healer, would be difficult or impossible to control, and would pose serious societal risks.” For this reason, all of the foregoing reasons, and even many more, it would be both the wise and compassionate path for the nation’s capital to focus on supporting hospice and palliative care programs instead of legal assisted suicide.

 

Genevieve Plaster is Senior Policy Analyst at the Charlotte Lozier Institute. 

Latest Posts

February 1, 2023 Abortion Reporting: Hawaii (2020) January 30, 2023 Abortion Reporting: Pennsylvania (2021) January 27, 2023 Abortion Reporting: Maine (2021)

You Might Also Be Interested In

NEBRASKA FACT CHECK: Heart Rate at Six Weeks is 110 Beats Per Minute

charlotte-lozier-institute Charlotte Lozier Institute
January 11, 2023

VIRGINIA FACT CHECK: Science Demonstrates Unborn Babies Feel Pain by 15 Weeks

charlotte-lozier-institute Charlotte Lozier Institute
January 11, 2023
The Effort to Reinterpret EMTALA to Mandate Abortions

The Effort to Reinterpret EMTALA to Mandate Abortions

November 8, 2022

Become A Defender of Life

Your donation helps us continue to provide world-
class research in defense of life.

BECOME A PARTNER
cta-image